Constantinescu SN - Search Results

1

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.

Willekens C, Laplane L, Dagher T, Benlabiod C, Papadopoulos N, Lacout C, Rameau P, Catelain C, Alfaro A, Edmond V, Signolle N, Marchand V, Droin N, Hoogenboezem R, Schneider RK, Penson A, Abdel-Wahab O, Giraudier S, Pasquier F, Marty C, Plo I, Villeval JL, Constantinescu SN, Porteu F, Vainchenker W, Solary E. Willekens C, et al. Among authors: constantinescu sn. Leukemia. 2023 Jun;37(6):1287-1297. doi: 10.1038/s41375-023-01878-0. Epub 2023 Apr 26. Leukemia. 2023. PMID: 37100881

2

The priming effect of human interferon-alpha is mediated by protein kinase C.

Constantinescu SN, Cernescu C, Balta F, Maniu H, Popescu LM. Constantinescu SN, et al. J Interferon Res. 1990 Dec;10(6):589-97. doi: 10.1089/jir.1990.10.589. J Interferon Res. 1990. PMID: 1964949

3

HCV seroprevalence in dialysis patients, their relatives and medical staff.

Capşa D, Cernescu S, Constantinescu SN, Cernescu C. Capşa D, et al. Among authors: constantinescu sn. Rev Roum Virol. 1991 Jul-Dec;42(3-4):171-5. Rev Roum Virol. 1991. PMID: 1667584

4

HIV-1 infection in Romanian children.

Patrascu IV, Constantinescu SN, Dublanchet A. Patrascu IV, et al. Among authors: constantinescu sn. Lancet. 1990 Mar 17;335(8690):672. doi: 10.1016/0140-6736(90)90466-i. Lancet. 1990. PMID: 1969055 No abstract available.

5

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, Garçon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W. James C, et al. Among authors: constantinescu sn. Nature. 2005 Apr 28;434(7037):1144-8. doi: 10.1038/nature03546. Nature. 2005. PMID: 15793561

6

Role of tyrosine kinases and phosphatases in polycythemia vera.

Zhao ZJ, Vainchenker W, Krantz SB, Casadevall N, Constantinescu SN. Zhao ZJ, et al. Among authors: constantinescu sn. Semin Hematol. 2005 Oct;42(4):221-9. doi: 10.1053/j.seminhematol.2005.05.019. Semin Hematol. 2005. PMID: 16210035 Review.

7

JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor.

Staerk J, Kallin A, Demoulin JB, Vainchenker W, Constantinescu SN. Staerk J, et al. Among authors: constantinescu sn. J Biol Chem. 2005 Dec 23;280(51):41893-9. doi: 10.1074/jbc.C500358200. Epub 2005 Oct 19. J Biol Chem. 2005. PMID: 16239216 Free article.

8

An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.

Staerk J, Lacout C, Sato T, Smith SO, Vainchenker W, Constantinescu SN. Staerk J, et al. Among authors: constantinescu sn. Blood. 2006 Mar 1;107(5):1864-71. doi: 10.1182/blood-2005-06-2600. Epub 2005 Oct 25. Blood. 2006. PMID: 16249382 Free PMC article.

9

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects.

James C, Ugo V, Casadevall N, Constantinescu SN, Vainchenker W. James C, et al. Among authors: constantinescu sn. Trends Mol Med. 2005 Dec;11(12):546-54. doi: 10.1016/j.molmed.2005.10.003. Epub 2005 Nov 3. Trends Mol Med. 2005. PMID: 16271512 Review.

10

A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases.

Vainchenker W, Constantinescu SN. Vainchenker W, et al. Among authors: constantinescu sn. Hematology Am Soc Hematol Educ Program. 2005:195-200. doi: 10.1182/asheducation-2005.1.195. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters